A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
| Autor principal: | Khan, Muidul Hasan |
|---|---|
| Otros Autores: | Khair, Nishat Zareen |
| Formato: | Tesis |
| Lenguaje: | English |
| Publicado: |
Brac University
2024
|
| Materias: | |
| Acceso en línea: | http://hdl.handle.net/10361/23233 |
Ejemplares similares
-
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
por: Flora, Sanzida Alam
Publicado: (2024) -
Detection of acute Lymphocytic Leukemia (ALL) and its type by image processing and machine learning
por: Chowdhury, Himadri, et al.
Publicado: (2019) -
A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
por: Sorno, Rubina Haque
Publicado: (2024) -
CAR-T cell Therapy in B-cell Lymphoma
por: Faruk, Asef
Publicado: (2020) -
A review on bispecific antibody (blinatumomab) for the treatment of acute lymphoblastic leukemia
por: Choki, Kinley
Publicado: (2024)